Twist Bioscience Corporation (TWST)

Twist Bioscience Corporation is a biotechnology company founded in 2013 by Emily Leproust, who also serves as its CEO. The company is headquartered in South San Francisco, California. Twist Bioscience specializes in synthetic DNA technology, providing high-quality DNA synthesis for academic and commercial use in industries like healthcare, agriculture, and pharmaceuticals. They are known for their innovative silicon-based DNA writing platform, which enables precise and efficient synthesis of DNA at scale. The company’s technology supports advancements in genetic research, drug development, and personalized medicine. In the fiscal year 2022, Twist Bioscience reported revenues of approximately $203.6 million, showcasing significant growth in the rapidly expanding field of synthetic biology.